Formulation Design and Characterization of Lamivudine Controlled Release Matrix Tablets

Main Article Content

Itishree Jogamaya Das

Abstract

Aim: To design and characterize oral controlled release matrix tablets of lamivudine to improve efficacy and patient compliance. Materials and Methods: Lamivudine matrix tablets were prepared by wet granulation method using various proportions of hydrophilic polymers such as sodium carboxymethylcellulose (Na CMC), hydroxypropyl methylcellulose (HPMC), Eudragit-L155, and xanthan gum alone or in combination with hydrophobic polymer ethyl cellulose (EC). In-vitro release studies were performed using USP Type II dissolution apparatus 900 ml of pH - 6.8 phosphate buffer at 100 rpm. Drug release kinetics was analyzed using zero-order, first-order, Higuchi and Hixon equation. No chemical interaction between drug and the polymer was seen as confirmed by Fourier transform infrared studies. Results and Discussion: All the formulations showed good results which were compliance with pharmacopeial standards. Formulations X2, X3, X4, X5, X7, X9, X12, and X14 containing a combination of two polymers, i.e., xanthan gum, combine with EC, Na CMC, HPMC, and Eudragit-L155 in the different ratios shows zero-order kinetic of release with 80-97% of drug released. But in the presence of Na CMC in the formulation X4, X9, and X14, the drug released in 12 h was in the range of 75-85% and shows zero-order kinetics. Mathematical analysis of the release kinetics indicated that the nature of drug release from the matrix tablets was dependent on drug diffusion and therefore followed non-Fickian or anomalous release. The formulation X4 containing xanthan gum with Na CMC gave more sustaining action, i.e., 79.16% in 12 h. Conclusion: Based on the in-vitro drug release study, it can be concluded that among the prepared formulations, X4 is the optimized formulation and can overcome the demerits of conventional lamivudine tablet.

Downloads

Download data is not yet available.

Article Details

How to Cite
Das, I. J. (2017). Formulation Design and Characterization of Lamivudine Controlled Release Matrix Tablets. Asian Journal of Pharmaceutics (AJP), 11(02). https://doi.org/10.22377/ajp.v11i02.1271
Section
ORIGINAL ARTICLES